Use evidence to support early coverage of gene therapy after accelerated approval
Gene therapies represent an evidence problem. Because they are just beginning to be used, little long-term data exists on their effectiveness and downstream risks.
Gene therapies represent an evidence problem. Because they are just beginning to be used, little long-term data exists on their effectiveness and downstream risks.
Alignment Healthcare boosted its health plan membership and is now projecting a higher full-year growth range, the insurtech announced ahead of its first-quarter earnings call.…
This secondary analysis of a randomized clinical trial evaluates the temporal association between 72-hour hazard periods of exposure to red blood cell (RBC) transfusions and…
The fire sale of Silicon Valley Bank is nearly complete.
Japanese telecom firms unveil a 6G wireless device, 20 times faster than 5G, with 100 Gbps data transmission up to 330 feet.
Bats are among the most diverse mammalian species, representing over 20% of mammalian diversity. The past two decades have witnessed a disproportionate spillover of viruses…
Explore special articles published online first to coincide with presentations at the Pediatric Academic Societies Meeting.
Explore special articles published online first to coincide with presentations at the Pediatric Academic Societies Meeting.
Background The triglyceride glucose (TyG) index and triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio are recognized as simple non-insulin-based insulin resistance indices. Our study aimed to explore…
General Catalyst, Providence’s venture arm and 7WireVentures were among the notable digital health investors this week.
Nature Reviews Chemistry – To achieve net-zero carbon emissions, we must close the carbon cycle for industries that are difficult to electrify. Developing the needed…